Alcon AG | ALC - Selling And Administration Expenses

Stock Price
60.96
Daily Change
0.48 0.79%
Monthly
-4.06%
Yearly
-27.27%
Q1 Forecast
60.90

Alcon AG reported $865M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 148M 4.86B Sep/2025
Bayer EUR 3.4B 140M Sep/2025
Essilor EUR 1.09B 2.08B Jun/2025
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
GlaxoSmithKline GBP 2.16B 19M Sep/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Merck EUR 1.46B 16M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Philips EUR 1.18B 61M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
Sonova Holding CHF 880.2M 300K Jun/2025
UCB EUR 1.29B 221M Dec/2024